StreetAlpha.app
Home › Stocks › LFCR

Lifecore Biomedical, Inc. (LFCR)

Healthcare
$6.39
▼ −0.39%
LAST CLOSE · NOV 17

Lifecore Biomedical makes sterile injectable drugs and medical devices under contract for pharmaceutical and biotechnology companies. It last closed at $6.39 on Nov 17, down 0.39% on the day.

AI Auto Pilots
Is LFCR in one of our four AI portfolios? Sign in free to see

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated LFCR in the past 90 days, not enough for a consensus
Average 12-month target
$8.00
▲ 25.2% upside

Based on 1 analyst who set a price target on LFCR in the past 90 days. The average target is $8.00, with a high of $8.00 and a low of $8.00, compared with the last close of $6.39.

Low $8.00Avg $8.00High $8.00
Blue marker: last close $6.39
Highest target$8.00
Average target$8.00
Lowest target$8.00
Latest rating changes
Craig-HallumInitiated
Sep 25Buy$8
Barrington ResearchTarget raised
Jun 16Buy$5.50 → $6.50
Barrington ResearchUpgrade
Mar 17Buy$5.50
DateFirmActionRatingPrice target
Sep 25Craig-HallumInitiatedBuy$8
Jun 16Barrington ResearchTarget raisedBuy$5.50 → $6.50
Mar 17Barrington ResearchUpgradeBuy$5.50
Loading…

Technical Analysis

LFCR · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 16% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 60). The nearest support is the Pivot S1 at $6.38, and the nearest resistance the Pivot at $6.40.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityLow, 1.1%/day
Key levels
$8.9852 week high+40.5%
$6.48Swing high (Oct 15)+1.4%
$6.4120 day average+0.3%
$6.41Pivot R1+0.3%
$6.40Pivot+0.2%
$6.39Last close
$6.38Pivot S1−0.2%
$6.36Swing low (Oct 21)−0.5%
$5.8850 day average−8.0%
$5.39200 day average−15.6%
$5.25100 day average−17.8%
$3.6352 week low−43.2%
Indicators
RSI (14)60.36Strong, overbought above 70Neutral
MACD0.10Below its signal lineBearish
Stochastic44.2Middle of its rangeNeutral
ADX (14)30.2Trending up
Williams %R-65.0Oversold below −80, overbought above −20Neutral
CCI (20)-22.5Oversold below −100, overbought above 100Neutral
Rate of change−0.5%Change over 10 sessionsBearish
ATR (14)$0.07Typical daily range, 1.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for LFCR

What happened before

See how LFCR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow LFCR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How LFCR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in LFCR in the last 90 days.

Loading…

See today’s whale options flow across the market →

LFCR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●48 buying vs 44 selling
  • ●Shares held by funds +0.1%
  • ▲Funds holding +5
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding105100+5.0%
In funds' top 10440.0%
Held by funds–––
New / increased16 / 3215 / 35−4.0%
Reduced / sold out33 / 1123 / 19+4.8%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See LFCR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LFCR is in one of them and how their past LFCR trades turned out.

LFCR in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered LFCR in an article yet. Here's the latest on the wider market.

About Lifecore Biomedical

Lifecore Biomedical is a contract development and manufacturing organization based in Chaska, Minnesota. It develops and makes sterile injectable drugs and medical devices, filled into syringes, vials and cartridges. The company also produces hyaluronic acid, made by fermentation, in bulk form and for use in injectables used in eye and joint treatments. Its customers include pharmaceutical, biotechnology and device companies that rely on its aseptic filling and regulatory expertise.

Headquarters
Chaska, MN